Product Information
ORACEA 40 MG CAPSULE is a brand product labeled by Galderma Laboratories, L.P., priced at $29.0899 per EA under NDC 00299382230. Its NADAC has been published 537 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the DOXYCYCLINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Galderma Laboratories, L.P.NDC
00299382230
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXYCYCLINEApproval Type
New Drug (NDA)
FDA Application
NDA050805On Market Since
5/14/2010
Pharmacological Classes
Price Statistics
The NADAC for ORACEA 40 MG CAPSULE has been published 537 times since Nov 28, 2013, and over the history we have for it it has risen 116.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $29.0899 per EA |
|---|---|
| All-time high | $29.2025 (May 14, 2025) |
| All-time low | $13.4339 (Nov 28, 2013) |
| 52-week high | $29.1564 |
| 52-week low | $29.0899 |
| Median price | $22.5441 |
| Average price | $22.5184 |
| Largest weekly change | +14.9% (Feb 11, 2015) |
| Weeks tracked | 537 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 80% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ORACEA 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ORACEA 40 MG CAPSULE, manufactured by Galderma Laboratories, L.P., is $29.0899 per EA (NDC 00299382230), effective Jun 24, 2026.
How has the price of ORACEA 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ORACEA 40 MG CAPSULE has risen 116.5%. It has been tracked across 537 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ORACEA 40 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ORACEA 40 MG CAPSULE has ranged from a low of $13.4339 (Nov 28, 2013) to a high of $29.2025 (May 14, 2025), with a median of $22.5441 per EA.
Are there cheaper alternatives to ORACEA 40 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DOXYCYCLINE IR-DR 40 MG CAP, is $5.8492 per EA — about 80% below ORACEA 40 MG CAPSULE.
Who manufactures ORACEA 40 MG CAPSULE?
ORACEA 40 MG CAPSULE (NDC 00299382230) is labeled by Galderma Laboratories, L.P., and CMS classifies it as a brand product.
Related Drugs
Same classification